The Sialyltransferase ST3GAL6 Influences Homing and Survival in Multiple Myeloma
Overview
Authors
Affiliations
Glycosylation is a stepwise procedure of covalent attachment of oligosaccharide chains to proteins or lipids, and alterations in this process, especially increased sialylation, have been associated with malignant transformation and metastasis. The role of altered sialylation in multiple myeloma (MM) cell trafficking has not been previously investigated. In the present study we identified high expression of β-galactoside α-2,3-sialyltransferase, ST3GAL6, in MM cell lines and patients. This gene plays a key role in selectin ligand synthesis in humans through the generation of functional sialyl Lewis X. In MRC IX patients, high expression of this gene is associated with inferior overall survival. In this study we demonstrate that knockdown of ST3GAL6 results in a significant reduction in levels of α-2,3-linked sialic acid on the surface of MM cells with an associated significant reduction in adhesion to MM bone marrow stromal cells and fibronectin along with reduced transendothelial migration in vitro. In support of our in vitro findings, we demonstrate significantly reduced homing and engraftment of ST3GAL6 knockdown MM cells to the bone marrow niche in vivo, along with decreased tumor burden and prolonged survival. This study points to the importance of altered glycosylation, particularly sialylation, in MM cell adhesion and migration.
Zhang P, Wang L, Liu H, Lin S, Guo D BMC Cancer. 2025; 25(1):249.
PMID: 39948531 PMC: 11823056. DOI: 10.1186/s12885-025-13650-x.
Recent advances in and applications of ex vivo drug sensitivity analysis for blood cancers.
Lee H, Ko N, Namgoong S, Ham S, Koo J Blood Res. 2024; 59(1):37.
PMID: 39503808 PMC: 11541977. DOI: 10.1007/s44313-024-00032-8.
: An Underexplored p53 Target Gene Linking Glycosylation and Cancer Progression.
Hu D, Kobayashi N, Ohki R Cancers (Basel). 2024; 16(15).
PMID: 39123480 PMC: 11311387. DOI: 10.3390/cancers16152753.
The genetics and epidemiology of N- and O-immunoglobulin A glycomics.
Visconti A, Rossi N, Bondt A, Ederveen A, Thareja G, Koeleman C Genome Med. 2024; 16(1):96.
PMID: 39123268 PMC: 11312925. DOI: 10.1186/s13073-024-01369-6.
Specific sialylation of N-glycans and its novel regulatory mechanism.
Gu J, Isaji T Glycoconj J. 2024; 41(3):175-183.
PMID: 38958800 PMC: 11329402. DOI: 10.1007/s10719-024-10157-8.